Glucotrack, Inc. completes bridge financing to support strategic growth initiatives. E.F. Hutton & Co. advised on the funding, aimed at enhancing the combined platform with Lōkahi Therapeutics.
Round Type
Venture
RutherfordBiotechnologyHealthcareInvestors
Description
Glucotrack, Inc. has announced the completion of a bridge financing to support its strategic growth objectives post the business combination with Lōkahi Therapeutics. This financing will facilitate the advancement of the combined platform and other capital markets initiatives. E.F
Quick answer
Glucotrack raised an undisclosed amount in a funding round, dated July 17, 2026. Investors: E.F. Hutton & Co. Glucotrack is based in Rutherford, New Jersey, United States.
- How much did Glucotrack raise?
- Glucotrack raised an undisclosed amount in a funding round on July 17, 2026.
- Who invested in Glucotrack?
- E.F. Hutton & Co. is named as investors in this round.
- What does Glucotrack do?
- Glucotrack, Inc. is focused on the design, development, and commercialization of novel technologies for people with diabetes, including a long-term implantable continuous blood glucose monitoring system.
- Where is Glucotrack based and how big is it?
- Glucotrack is based in Rutherford, New Jersey, United States. Fundz records about 15 employees.
- Who are the decision-makers at Glucotrack?
- Fundz holds 2 contacts at Glucotrack, including the Head of Software. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Glucotrack that raised within 45 days of this round, from Fundz verified event records.
- Tenon Medical raised $4.3M (Series A) on August 31, 2026.
- Corvex Legacy Holdings raised $33M on August 31, 2026.
- Endovia Health Sciences, Inc. raised $108K (Funding Round) on August 28, 2026.
- Tenon Medical raised $3M (Post-IPO Equity) on August 28, 2026.
- BioLineRx Ltd raised $3.8M on August 27, 2026.
- Amylyx Pharmaceuticals raised $500M (Post-IPO Equity) on August 20, 2026.
Who to call at Glucotrack, and when
A new round usually means Glucotrack is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Glucotrack raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Glucotrack, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Glucotrack. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Glucotrack raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Glucotrack raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.